Notable Platform Presentations in Drug Discovery and Development
Monday April 06, 2020
4:50 pm
-
6:00 pm
Eastern Time (ET)
Room 15 B
DDD
Chair :
Don Button
Adamas Pharmaceuticals, Inc.
Tom Parry
Ovid Therapeutics
Benita Sjogren
Purdue Univ
This abstract-based showcase platform session features students and postdoctoral fellows with talks that range from basic drug discovery to drug development.
Speakers
Andrew Robles
- UT Health San Antonio
Deciphering the Mechanisms of Action of Altertoxin II with Genome-Wide CRISPR/Cas9 Knockout Screening
Scarlett Desclaux
- Mahidol University
ALGX-XC20, a Novel Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonist Attenuates Joint Pain and Articular Cartilage Damage in an Osteoarthritis Rat Model
Keith Olson
- University of Michigan
Buprenorphine Analogs to Treat Relapse
Sarah Freeman
- West Virginia University
CLIC1 is an Attractive Candidate for the Initial Binding Target of the Novel Peptide MTI-101
Justin Chen
- Washington State University
Discovery of High Affinity γ-Hydroxybutyrate (GHB) Receptor Ligands for SSADH Deficiency, a Disorder of GABA Metabolism